ALPHARETTA, Ga., Feb. 28, 2017 -- Aptean is pleased to announce their sponsorship and attendance at LogiMed US, a premier conference for medical device suppliers, taking place in Austin, Texas, March 7-9th, 2017. Aptean is a leading global provider of mission critical enterprise software solutions, including Supply Chain Management (SCM), and serves more than 6,500 customers worldwide.
LogiMed brings together some of the biggest healthcare solution providers, including medical device manufacturers and service providers, and supply chain experts. Aptean has extended its SCM reach into the healthcare sector and will focus on showcasing their top medical supply chain complimentary solutions, including:
- Catalyst Warehouse Management System (WMS)
- i-Supply Collaborative Inventory Management
- Verdiem PC Fleet Management
- irms|360 Enterprise Solutions cloud-based WMS software
“In recent years the medical supply chain industry has become significantly more complex and demanding. Aptean is committed to helping our customers solve those challenges and achieve results with our deep industry knowledge and leading supply chain solutions," said Brad Steger, Senior Vice President Process ERP and Supply Chain Management Product Group. “We are looking forward to connecting with leaders in the medical supply chain industry at LogiMed US.”
For more information, LogiMed attendees should visit booth #11 at the event to speak with Aptean’s medical supply chain experts and view demos of their Catalyst and i-Supply solutions.
To learn more about the LogiMed event or register as an attendee, please visit http://logimedusa.wbresearch.com/.
ABOUT APTEAN
Aptean is a leading global provider of mission critical enterprise software solutions. We build and acquire industry-focused solutions to support the evolving operational needs of our customers. Our solutions help nearly 6,500 organizations stay at the forefront of their industries by enabling them to operate more efficiently, thereby ensuring higher customer satisfaction. For more information, visit www.aptean.com.
Aptean is a trademark of Aptean, Inc. All other company and product names may be trademarks of the respective companies with which they are associated.
FOR MORE INFORMATION Media Relations Melissa Floyd, Aptean [email protected]


SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks
Want to cut your energy bills? Here’s how five experts are doing it
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
John Ternus Signals Apple’s Future with Product-First AI Strategy
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns 



